US Stock MarketDetailed Quotes

Sangamo Therapeutics (SGMO)

Watchlist
  • 0.1901
  • -0.0649-25.45%
Close Apr 24 15:59 ET
  • 0.1800
  • -0.0101-5.31%
Post 19:59 ET
78.75MMarket Cap-0.43P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics (SGMO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-31.57%39.55M
88.43%14.23M
-98.82%581K
5,042.13%18.31M
1,238.25%6.44M
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
Operating revenue
-31.57%39.55M
88.43%14.23M
-98.82%581K
5,042.13%18.31M
1,238.25%6.44M
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
Cost of revenue
Gross profit
Operating expense
-5.56%147.56M
16.86%39.2M
-6.83%36.13M
-0.30%36.16M
-24.33%36.07M
-47.07%156.25M
-47.43%33.54M
-45.38%38.78M
-54.13%36.27M
-41.42%47.66M
Selling and administrative expenses
-22.00%34.89M
-21.37%7.76M
-27.67%7.99M
-24.64%9.08M
-14.52%10.06M
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
-General and administrative expense
-22.00%34.89M
-21.37%7.76M
-27.67%7.99M
-24.64%9.08M
-14.52%10.06M
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
Research and development costs
1.03%112.67M
32.79%31.44M
1.48%28.14M
11.81%27.08M
-27.54%26.01M
-52.35%111.52M
-53.31%23.68M
-51.42%27.73M
-61.58%24.22M
-43.22%35.89M
Operating profit
-9.71%-108M
3.93%-24.97M
-434.43%-35.55M
50.28%-17.86M
37.20%-29.63M
17.27%-98.45M
57.92%-25.99M
117.26%10.63M
50.28%-35.91M
-161.58%-47.18M
Net non-operating interest income expense
-13.95%1.3M
-14.86%252K
1.43%355K
-7.21%386K
-31.49%309K
-86.37%1.51M
-80.16%296K
-90.04%350K
-85.15%416K
-86.30%451K
Non-operating interest income
-13.95%1.3M
-14.86%252K
1.43%355K
-7.21%386K
-31.49%309K
-86.37%1.51M
-80.16%296K
-90.04%350K
--416K
--451K
Total other finance cost
----
----
----
----
----
----
----
----
63.24%-1.03M
23.02%-2.54M
Other net income (expense)
-1,332.05%-16.8M
-808.50%-13.26M
148.42%107K
-346.24%-2.49M
48.83%-1.16M
99.24%-1.17M
732.09%1.87M
99.51%-221K
98.91%-558K
96.13%-2.27M
Special income (charges)
-139.72%-13.24M
---13.24M
--0
--0
--0
96.44%-5.52M
--0
--0
97.72%-1.17M
92.57%-4.35M
-Less:Impairment of capital assets
139.72%13.24M
--13.24M
--0
--0
--0
-96.44%5.52M
--0
--0
-97.72%1.17M
-92.57%4.35M
Other non- operating income (expenses)
-181.95%-3.56M
-101.12%-21K
148.42%107K
-505.54%-2.49M
-155.61%-1.16M
--4.35M
--1.87M
---221K
--614K
--2.08M
Income before tax
-25.88%-123.5M
-59.39%-37.97M
-426.12%-35.09M
44.64%-19.96M
37.79%-30.48M
62.68%-98.11M
60.67%-23.82M
110.46%10.76M
70.15%-36.05M
-329.71%-48.99M
Income tax
-240.12%-568K
-29.51%-553K
-282.95%-161K
-63.51%27K
21.43%119K
96.71%-167K
-56.99%-427K
-93.07%88K
101.18%74K
-49.48%98K
Net income
-25.52%-122.93M
-59.94%-37.42M
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
Net income continuous Operations
-25.52%-122.93M
-59.94%-37.42M
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
Minority interest income
Net income attributable to the parent company
-25.52%-122.93M
-59.94%-37.42M
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
Preferred stock dividends
Other preferred stock dividends
0
1.29M
Net income attributable to common stockholders
-25.52%-122.93M
-59.94%-37.42M
-472.19%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
109.01%9.39M
68.45%-36.13M
-332.29%-49.09M
Basic earnings per share
10.20%-0.44
0.00%-0.11
-320.00%-0.11
55.56%-0.08
48.15%-0.14
66.89%-0.49
67.65%-0.11
108.47%0.05
72.73%-0.18
-307.69%-0.27
Diluted earnings per share
10.20%-0.44
0.00%-0.11
-375.00%-0.11
55.56%-0.08
48.15%-0.14
66.89%-0.49
67.65%-0.11
106.78%0.04
72.73%-0.18
-325.00%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -31.57%39.55M88.43%14.23M-98.82%581K5,042.13%18.31M1,238.25%6.44M-67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K
Operating revenue -31.57%39.55M88.43%14.23M-98.82%581K5,042.13%18.31M1,238.25%6.44M-67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K
Cost of revenue
Gross profit
Operating expense -5.56%147.56M16.86%39.2M-6.83%36.13M-0.30%36.16M-24.33%36.07M-47.07%156.25M-47.43%33.54M-45.38%38.78M-54.13%36.27M-41.42%47.66M
Selling and administrative expenses -22.00%34.89M-21.37%7.76M-27.67%7.99M-24.64%9.08M-14.52%10.06M-26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M
-General and administrative expense -22.00%34.89M-21.37%7.76M-27.67%7.99M-24.64%9.08M-14.52%10.06M-26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M
Research and development costs 1.03%112.67M32.79%31.44M1.48%28.14M11.81%27.08M-27.54%26.01M-52.35%111.52M-53.31%23.68M-51.42%27.73M-61.58%24.22M-43.22%35.89M
Operating profit -9.71%-108M3.93%-24.97M-434.43%-35.55M50.28%-17.86M37.20%-29.63M17.27%-98.45M57.92%-25.99M117.26%10.63M50.28%-35.91M-161.58%-47.18M
Net non-operating interest income expense -13.95%1.3M-14.86%252K1.43%355K-7.21%386K-31.49%309K-86.37%1.51M-80.16%296K-90.04%350K-85.15%416K-86.30%451K
Non-operating interest income -13.95%1.3M-14.86%252K1.43%355K-7.21%386K-31.49%309K-86.37%1.51M-80.16%296K-90.04%350K--416K--451K
Total other finance cost --------------------------------63.24%-1.03M23.02%-2.54M
Other net income (expense) -1,332.05%-16.8M-808.50%-13.26M148.42%107K-346.24%-2.49M48.83%-1.16M99.24%-1.17M732.09%1.87M99.51%-221K98.91%-558K96.13%-2.27M
Special income (charges) -139.72%-13.24M---13.24M--0--0--096.44%-5.52M--0--097.72%-1.17M92.57%-4.35M
-Less:Impairment of capital assets 139.72%13.24M--13.24M--0--0--0-96.44%5.52M--0--0-97.72%1.17M-92.57%4.35M
Other non- operating income (expenses) -181.95%-3.56M-101.12%-21K148.42%107K-505.54%-2.49M-155.61%-1.16M--4.35M--1.87M---221K--614K--2.08M
Income before tax -25.88%-123.5M-59.39%-37.97M-426.12%-35.09M44.64%-19.96M37.79%-30.48M62.68%-98.11M60.67%-23.82M110.46%10.76M70.15%-36.05M-329.71%-48.99M
Income tax -240.12%-568K-29.51%-553K-282.95%-161K-63.51%27K21.43%119K96.71%-167K-56.99%-427K-93.07%88K101.18%74K-49.48%98K
Net income -25.52%-122.93M-59.94%-37.42M-427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M
Net income continuous Operations -25.52%-122.93M-59.94%-37.42M-427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M
Minority interest income
Net income attributable to the parent company -25.52%-122.93M-59.94%-37.42M-427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M
Preferred stock dividends
Other preferred stock dividends 01.29M
Net income attributable to common stockholders -25.52%-122.93M-59.94%-37.42M-472.19%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M109.01%9.39M68.45%-36.13M-332.29%-49.09M
Basic earnings per share 10.20%-0.440.00%-0.11-320.00%-0.1155.56%-0.0848.15%-0.1466.89%-0.4967.65%-0.11108.47%0.0572.73%-0.18-307.69%-0.27
Diluted earnings per share 10.20%-0.440.00%-0.11-375.00%-0.1155.56%-0.0848.15%-0.1466.89%-0.4967.65%-0.11106.78%0.0472.73%-0.18-325.00%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -